App Store

Google Play

DK - Details page - Device banner - 894x1036

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

Lyt når som helst, hvor som helst 

Financial Times

From hostile takeovers to C-suite intrigue, Behind the Money takes you inside the business and financial stories of the moment with reporting from Financial Times journalists around the world. 

 Hosted on Acast. See acast.com/privacy for more information.


Behind the Money

This week, Michela joins live from the FT’s Global Banking Summit in London. She sits down with three reporters and editors to analyse how the banking industry will shape up during Donald Trump’s second term in the White House. She’s joined by the FT’s US financial editor Brooke Masters and banking editor Ortenca Aliaj alongside Michael Klimes, investment banking and capital markets editor at The Banker. They discuss what banks stand to gain and lose, and what the industry may look like four years from now. 

The conversation was recorded on December 3 2024. 

- - - - - - - - - - - - - - - - - - - - - - - - - - 

For further reading:

A Wall Street giddy over Trump should remember history

In Donald Trump, Wall Street will get what it wanted — and what it did not

Trump 2.0: winners, losers and Elon

- - - - - - - - - - - - - - - - - - - - - - - - - - 

Michela recently joined Bluesky, follow her there: @mtindera.bsky.social, Her guests are also on Bluesky: Brooke Masters (@brookeamasters.bsky.social) and Ortenca Aliaj (@ortenca.bsky.social), or follow Michael Klimes reporting at FT’s The Banker (@thebanker.bsky.social) 

Read a transcript of this episode on FT.com

 Hosted on Acast. See acast.com/privacy for more information.

What Trump’s presidency means for banking

A weekly podcast from the Financial Times that digs into the big business and financial stories in the news. Behind The Money starts Tuesday, May 1. 

 Hosted on Acast. See acast.com/privacy for more information.

Coming soon

The Trump administration blocked chipmaker Broadcom's bid to acquire rival Qualcomm on the grounds of national security. But how did the San Diego-based company become the target in the first place? And who will ultimately own the mobile technology of the future? 

With FT reporters James Fontanella-Khan and Tim Bradshaw.

News review clips: C-Span, Fox News. 

 Hosted on Acast. See acast.com/privacy for more information.

What happened at Qualcomm?

Record numbers of bankruptcies and store closures have devastated the retail sector. So why is the beauty market thriving? Will the likes of Sephora and Ulta be able to ward off Amazon? With guests Moj Mahdara, chief executive of Beautycon, and Simeon Siegel, analyst at Nomura Instinet. Read more on this story here. 

 Hosted on Acast. See acast.com/privacy for more information.

How beauty is beating the rest of retail

The co-working and office providing company set out to create the office of the future and has caught the attention of big investors, including SoftBank's Vision Fund. Will office subleasing open the door to profit for WeWork? With FT guests Dan Thomas and Alex Scaggs. 

Read more from Dan and Alex at FT.com. Music by Podington Bear. 

 Hosted on Acast. See acast.com/privacy for more information.

How WeWork really works

Some big name fast fashion retailers are sourcing their inventory closer to home in order to get the latest pieces into the hands of their shoppers fast. But how is it possible such labour intensive production is taking place in one of the most expensive economies in the world? With the FT's Sarah O'Connor. Read Sarah's feature here. 

 Hosted on Acast. See acast.com/privacy for more information.

The dark side of fast fashion

After Mauricio Macri came to power in 2015, international investors poured money into Argentina's hundred-year bond with the hopes that the centre-right leader would stabilise the economy after years of disarray. But less than three years later, the president is seeking a loan from the International Monetary Fund, in what some fear could be the the first major sign of the end of the global economic boom. With the FT's Gillian Tett, John Authers and John Paul Rathbone. News review clips: CNN, CNBC, Bloomberg, Al Jazeera English, Reuters. 

 Hosted on Acast. See acast.com/privacy for more information.

The economic crisis in Argentina explained

Rupert Murdoch built a global media empire across newspaper, television and film companies. Why is now the time for him to sell many of the 21st Century Fox assets? And which media or telecoms giant will scoop them up? With the FT's Matt Garrahan and Arash Massoudi. Read more on FT.com.

Review clips: CNN, CNBC, BBC, Fox News, Fox Business Network, Al Jazeera English, PBS News and CBS News.

 Hosted on Acast. See acast.com/privacy for more information.

The hunt for Fox

Medical marijuana is legal in 21 countries. In Canada, residents expect they will be able to buy cannabis from dispensaries and pharmacies across the country later this year. Some analysts have valued the legal business at anywhere between $7bn-$20bn, attracting a host of entrepreneurs and investors trying to get in on the action before the market takes off. We talk to two entrepreneurs with two very different plans to capitalise on the boom. With guests Norman Conde, Nick Kovacevich and the FT's Eric Platt. 

 Hosted on Acast. See acast.com/privacy for more information.

Following the cannabis money trail

After a week that began with a tense G7 summit and ended with the US imposing more tariffs on Chinese goods, many expected to see a big slide in financial markets. But stocks remained flat last week. Why aren't investors bracing for rockier times? With the FT's senior investment commentator John Authers.

Review clips: CTV News, PBS, CBS News, ABC News, CNN.

Contribute to our listener survey and enter our prize draw here.

 Hosted on Acast. See acast.com/privacy for more information.

Trump, trade and the markets

In the past month pharmaceutical companies have spent almost $100bn acquiring biotech companies. The FT's Sarah Neville explains why big pharma is raising its bet on the drug pipelines owned by biotechs, and why analysts expect more consolidation in 2019. 

Read more from Sarah at FT.com. 

 Hosted on Acast. See acast.com/privacy for more information.

Pharma raises its bet on biotech

Pharma raises its bet on biotech

Lyt når som helst, hvor som helst

Other podcasts you might like ...